Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Keitaro, Shimozaki"'
Autor:
Aya Nishizawa, Koichi Takeda, Tetsuya Urasaki, Makiko Ono, Toshiaki Mochizuki, Taro Shiga, Motohiro Fujiwara, Takeshi Yuasa, Atsushi Murakami, Ryo Koike, Mayu Yunokawa, Hiroyuki Kanao, Keitaro Shimozaki, Daisuke Takahari, Takahiro Kogawa, Shunji Takahashi, Shigehisa Kitano
Publikováno v:
JEADV Clinical Practice, Vol 2, Iss 2, Pp 330-337 (2023)
Abstract Immune checkpoint inhibitor (ICI) therapy is often associated with cutaneous immune‐related adverse events (irAEs). Drug eruptions stemming from concomitantly or consecutively administered medications are also frequent and tend to be sever
Externí odkaz:
https://doaj.org/article/1920eec3d1b2419e9855ae1e1e02aa61
Autor:
Keitaro Shimozaki1,2,3, Izuma Nakayama1, Daisuke Takahari1 daisuke.takahari@jfcr.or.jp, Kengo Nagashima4, Koichiro Yoshino1, Koshiro Fukuda1, Shota Fukuoka1, Hiroki Osumi1, Mariko Ogura1, Takeru Wakatsuki1, Akira Ooki1, Eiji Shinozaki1, Keisho Chin1, Kensei Yamaguchi1
Publikováno v:
Journal of Gastric Cancer. Oct2023, Vol. 23 Issue 4, p609-621. 13p.
Autor:
Hiroki Osumi, Eiji Shinozaki, Akira Ooki, Keitaro Shimozaki, Daisaku Kamiimabeppu, Izuma Nakayama, Takeru Wakatsuki, Mariko Ogura, Daisuke Takahari, Keisho Chin, Kensei Yamaguchi
Publikováno v:
Cancer Medicine, Vol 10, Iss 24, Pp 8820-8828 (2021)
Abstract Background Circulating tumor DNA (ctDNA) is a biomarker with potential to reflect comprehensive genomic information and overcome intratumor heterogeneity. In contrast, carcinoembryonic antigen (CEA) is a conventional tumor marker for predict
Externí odkaz:
https://doaj.org/article/c9f12771a9cf45ee8c0b5883f30ac9bb
Autor:
Keitaro Shimozaki, Hideyuki Hayashi, Shigeki Tanishima, Sara Horie, Akihiko Chida, Kai Tsugaru, Kazuhiro Togasaki, Kenta Kawasaki, Eriko Aimono, Kenro Hirata, Hiroshi Nishihara, Takanori Kanai, Yasuo Hamamoto
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Various malignancies exhibit high microsatellite instability (MSI-H) or mismatch repair deficiency (dMMR). The MSI-IVD kit, a polymerase chain reaction (PCR)-based method, was the first tumor-agnostic companion diagnostic to detect MSI statu
Externí odkaz:
https://doaj.org/article/9a1141042f2a419b9870c3b516403a9b
Publikováno v:
Cells, Vol 12, Iss 7, p 1049 (2023)
Since pembrolizumab, an anti-programmed death-1 (PD-1) antibody, showed a dramatic response to immunogenic cancers with microsatellite instability-high (MSI-H) and/or deficient mismatch repair (dMMR) in the pilot clinical trial KEYNOTE-016, subsequen
Externí odkaz:
https://doaj.org/article/877060fc525a4b3a9834796ecb16468f
Autor:
Keitaro Shimozaki, Kenro Hirata, Taro Sato, Maho Nakamura, Kyoko Kato, Hidekazu Hirano, Yosuke Kumekawa, Kaori Hino, Kentaro Kawakami, Yosuke Kito, Toshihiko Matsumoto, Takeshi Kawakami, Masato Komoda, Kengo Nagashima, Yasunori Sato, Kentaro Yamazaki, Shuichi Hironaka, Hiromasa Takaishi, Yasuo Hamamoto, Kei Muro
Publikováno v:
Clinical Colorectal Cancer. 21:339-346
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa68a6c4a0a65007d62f41fec7a6c880
https://doi.org/10.1016/j.clcc.2022.08.002
https://doi.org/10.1016/j.clcc.2022.08.002
Autor:
Daisaku, Kamiimabeppu, Takeru, Wakatsuki, Daisuke, Takahari, Naoki, Fukuda, Keitaro, Shimozaki, Hiroki, Osumi, Izuma, Nakayama, Mariko, Ogura, Akira, Ooki, Eiji, Shinozaki, Keisho, Chin, Kensei, Yamaguchi
Publikováno v:
International Journal of Clinical Oncology. 28:121-129
Alpha-Fetoprotein Producing Gastric Cancer (AFPGC) is an aggressive subgroup of gastric cancer. Recently ramucirumab has shown survival benefits in hepatocellular carcinoma, but only in those with higher Alpha-Fetoprotein (AFP) levels. However, the e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0861d4e65c86c0fcac53481dd8938996
https://doi.org/10.1007/s10147-022-02263-0
https://doi.org/10.1007/s10147-022-02263-0
Autor:
Masahiko Aoki, Shigenori Kadowaki, Naoki Takahashi, Takeshi Suzuki, Kotoe Oshima, Takayuki Ando, Yoshiyuki Yamamoto, Kentaro Kawakami, Yosuke Kito, Toshihiko Matsumoto, Keitaro Shimozaki, Yasuhiro Miyazaki, Toshifumi Yamaguchi, Michitaka Nagase, Takao Tamura, Yusuke Amanuma, Taito Esaki, Yuji Miura, Kohei Akiyoshi, Eishi Baba, Akitaka Makiyama, Yuji Negoro, Koji Nakashima, Naotoshi Sugimoto, Kengo Nagashima, Hirokazu Shoji, Narikazu Boku
Publikováno v:
Gastric Cancer. 26:132-144
Background Accelerated tumor growth during immunotherapy in pre-existing measurable lesions, hyperprogressive disease (HPD), has been reported. However, progression of non-measurable lesions and new lesions are frequently observed in patients with ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::408d12549590a8620de7e436df3477eb
https://doi.org/10.1007/s10120-022-01349-y
https://doi.org/10.1007/s10120-022-01349-y
Autor:
Koichiro Yoshino, Hiroki Osumi, Hiromichi Ito, Daisaku Kamiimabeppu, Akira Ooki, Takeru Wakatsuki, Keitaro Shimozaki, Izuma Nakayama, Mariko Ogura, Daisuke Takahari, Keisho Chin, Atsushi Oba, Yoshihiro Ono, Takafumi Sato, Yosuke Inoue, Yu Takahashi, Kensei Yamaguchi, Eiji Shinozaki
Publikováno v:
Annals of Surgical Oncology. 29:8385-8393
Colorectal cancer with liver metastasis (CLM) has high postoperative recurrence rates; therefore, optimizing perioperative treatment is imperative. Postoperative carcinoembryonic antigen (CEA) can aid in detecting minimal residual disease in colon ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::caec8368fc11ad508fdab651b2cb028a
https://doi.org/10.1245/s10434-022-12301-w
https://doi.org/10.1245/s10434-022-12301-w
Autor:
Akihiko Chida, Yasuo Hamamoto, Kenro Hirata, Yasunori Sato, Eiichiro So, Shotaro Kishimoto, Satoko Noguchi, Sara Horie, Yuki Saito, Keitaro Shimozaki, Kai Tsugaru, Kazuhiro Togasaki, Kenta Kawasaki, Hideyuki Hayashi, Takanori Kanai
Purpose: Palliative care should be provided for terminal cancer patients, but the remaining question is how oncologists are providing palliative care. Herein, we evaluated the effectiveness of palliative care provided via video telemedicine. Methods:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::583b25d3611cee3037a10a1fc05ade2f
https://doi.org/10.21203/rs.3.rs-2641713/v1
https://doi.org/10.21203/rs.3.rs-2641713/v1
